Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    Cell Transplant, Eye Transplant, Cellular Regeneration, Regeneration Therapy,

    Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    October 21, 2021
    Cloud Computing Magazine, AWS, Cloud, Cloud Computing, Explained, Key Terms, PaaS, SaaS, Data Science, Deep Learning, Machine Learning,IaaS, Cloud Portability, Remote Access, Security, Vertical Cloud, Consumer Cloud, Server, Network, Hybrid Systems, Multi-Tenancy, Xaas, Anything-as-a-Service, DaaS, PaaS, Software-as-a-Service, Software Applications, Work Solutions, Business Solutions, Enterprise Solutions, Remote Workforce, Productivity, Workforce Optimization, Platform-as-a-Service, Infrastructure-as-a-Service,Flexibility,Private Networks, Virtual Private Networks, VPN, Virtualization,

    Cloud-Based eDiscovery Creating Efficiencies for Law Firms

    January 19, 2016
    amazon prime first iot connected bike Yes, they really tried Amazon! Sorry, folks, a stationary bicycle made by the exercise gear company, Echelon, has no affiliation with Amazon and is not being sold as an exclusive “Prime Bike” to Amazon members.

    “That ain’t ours!” Company falsely claims Amazon partnership at product launch

    September 23, 2020
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    CBD Vape, Mood Management, Canopy Growth, Cannabis, Medical Cannabis, Mental Health, Toxic Free Vaping, Healthy Vaping, Health and Wellness,

    Change Your Mood with a Quick Hit: Canopy Growth Launches whisl, First-Ever CBD Vape

    September 15, 2021
    Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021
    Biotricity provides remote cardiac monitoring to patients through its biokit and Bioflux services. Biotricity's medtech technologies can be found in Samsung Watch4 devices and as a standalone platform at your local physical or health services provider.

    Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring

    September 15, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.